SURMOUNT-5 Trial Results This Phase 3b, open-label trial randomized 751 adults with obesity (but without diabetes) to receive either: Maximum tolerated dose of tirzepatide (10 mg or 15 mg) Maximum tolerated dose of semaglutide (1.7 mg or 2.4 mg) Key findings at 72 weeks: The trial concluded that tirzepatide was superior to semaglutide with respect to reduction in body weight and waist circumference at week 72
Its why we take such pains with our small-batch synthesis
Wear sunscreen with at least SPF 30 when going out during the day, and try to avoid the sun during peak hours (10 am to 4 pm)
66 Nevus of Ito is a type of congenital dermal melanocytosis involving areas of skin innervated by the posterior supraclavicular and lateral brachiocutaneous nerves
So, when you open that package from us, you're receiving the peptide in its most stable, pure, and potent form
When incorporating GLP-1 medication into a weight loss treatment plan, it is important to understand how this medication functions to aid in reducing body weight